Dream Team targets T-cell lymphoma using CAR-modified cells in experimental therapy
A Dream Team assembled by Stand Up To Cancer will receive $8 million in funding to research the use of modified immune cells to fight the rare and often deadly T-cell lymphoma, a type of blood cancer. Investigators either will use a patient’s own T cells — the warriors of the immune system — or a type of immune cells known as natural killer (NK) cells — the first line of defense against cancer cells.
Both approaches will use...
